NORCROSS, Ga.--(BUSINESS WIRE)--The National Cancer Institute (NCI) has designated the LuViva™ Advanced Cervical Scan by Guided Therapeutics, Inc. (OTCBB: GTHP) as one of the agency’s successful investments for developing innovative products to fight cancer.
